cobaltous chloride has been researched along with ferrous sulfate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikarashi, Y; Nakamura, A; Tsuchiya, T | 1 |
| Antonov, S; Boiadzhieva, A; Dilov, P; Iotov, M | 1 |
| Awazu, S; Horie, T; Yokoyama, H | 1 |
| Kim, JE; Sheen, YY | 1 |
| Arayne, MS; Sultana, N; Yasmeen, N | 1 |
| Li, W; Liu, S; Zhao, X | 1 |
6 other study(ies) available for cobaltous chloride and ferrous sulfate
| Article | Year |
|---|---|
Detection of contact sensitivity of metal salts using the murine local lymph node assay.
Topics: Animals; Cell Division; Cobalt; Dermatitis, Contact; Dimethyl Sulfoxide; Ear, External; Ethanol; Female; Ferrous Compounds; Lymph Nodes; Lymphocyte Activation; Metals; Mice; Pharmaceutical Vehicles; Potassium Dichromate; Skin; Skin Tests; Sulfates; Zinc; Zinc Sulfate | 1992 |
[Pharmacological and clinico-pharmacological studies of a combination preparation for calves having antianemia and general tonic action].
Topics: Absorption; Anemia; Animals; Cattle; Cattle Diseases; Cobalt; Copper; Copper Sulfate; Drug Combinations; Drug Evaluation; Drug Evaluation, Preclinical; Drug Tolerance; Ferrous Compounds; gamma-Globulins; Iron-Dextran Complex; Male; Mice; Protein Hydrolysates; Rats; Rats, Inbred Strains; Vitamin B 12 | 1983 |
Lipid peroxidation and chemiluminescence during naproxen metabolism in rat liver microsomes.
Topics: Animals; Antimutagenic Agents; Antioxidants; Ascorbic Acid; Cobalt; Electrophoresis, Polyacrylamide Gel; Ferrous Compounds; Histidine; Lipid Peroxidation; Luminescent Measurements; Magnesium Chloride; Male; Microsomes, Liver; Molecular Weight; NADP; Naproxen; Piperonyl Butoxide; Proadifen; Rats; Rats, Wistar; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Vitamin E | 1994 |
Inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-stimulated Cyp1a1 promoter activity by hypoxic agents.
Topics: Animals; Antimutagenic Agents; Cell Hypoxia; Cells, Cultured; Chelating Agents; Cobalt; Cytochrome P-450 CYP1A1; Deferoxamine; Dose-Response Relationship, Drug; Drug Interactions; Ferrous Compounds; Gene Expression Regulation, Enzymologic; Genes, Reporter; Luciferases; Mice; Oxygen; Picolinic Acids; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Time Factors | 2000 |
In vitro availability of ofloxacin in presence of metals essential to human body.
Topics: Anti-Bacterial Agents; Cadmium Chloride; Calcium Chloride; Chlorides; Chromium Compounds; Cobalt; Copper; Drug Interactions; Ferric Compounds; Ferrous Compounds; Gastric Juice; Humans; Hydrogen-Ion Concentration; Magnesium Chloride; Manganese Compounds; Nickel; Ofloxacin; Solubility; Spectrophotometry, Ultraviolet; Trace Elements; Zinc Compounds | 2007 |
Preparation of entangled nanocellulose fibers from APMP and its magnetic functional property as matrix.
Topics: Cellulose; Cobalt; Crystallization; Ferrous Compounds; Gels; Magnetic Fields; Nanofibers; Peroxides; Populus; Sonication; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry; Wood; X-Ray Diffraction | 2013 |